SELLAS Life Sciences Group, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Angelos Stergiou, with a market cap of $1.5B.
Based on Q1 2026 filing
Common questions about SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc. (SLS) has a market capitalization of $1.5B and trades on NASDAQ.
SELLAS Life Sciences Group, Inc. has approximately 17 employees.